Insulin glargine injection), 100 units/ml (U-100), 3mL prefilled pens

Recall fda-alert:2022-01-19:Semglee:Insulin glargine injection), 100 units/ml (U-100), 3mL prefilled pens · Published 2022-01-19

Official-information notice / 官方信息说明: This page transcribes fields from the named agency record. It is not medical, legal, or food-safety advice. Follow the agency's original notice and instructions.

Recall number / 召回编号

fda-alert:2022-01-19:Semglee:Insulin glargine injection), 100 units/ml (U-100), 3mL prefilled pens

Classification / 风险等级

Other / 其他

Published / 发布时间

2022-01-19

Recalling firm / 召回企业

Mylan Pharmaceutical Inc.

Product description / 产品描述

Insulin glargine injection), 100 units/ml (U-100), 3mL prefilled pens

Product code / 产品代码

Not provided in the official record

Code information / 批次与代码信息

Not provided in the official record

Product quantity / 产品数量

Not provided in the official record

Distribution / 销售地区

Not provided in the official record

Reason for recall / 召回原因

Missing Label

Open official source ↗ / 打开官方来源

Last synchronized: 2022-01-19. Recall Radar does not replace agency guidance.